People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AltheaDx, Inc. | — | Biotechnology | Series B | $51.8M | $137.3M | 2018 |
Feng Cao at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Feng Cao on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wei Li | 1 | 7 |
| Magda Marquet | 1 | 6 |
| Jason Liu | 1 | 4 |
| J. Matthew Mackowski | 1 | 4 |
| David Nikodem | 1 | 4 |
| Andrew Jackson | 1 | 4 |
| John Wu | 1 | 4 |
| Jeffrey G. Black | 1 | 3 |
| Yuh-geng Tsay | 1 | 2 |
| Deval A Lashkari | 1 | 2 |
| Francois Ferre | 1 | 2 |
| James B Glavin | 1 | 2 |
| Deval Matthew Lashkari | 1 | 1 |
| Greg Hamilton | 1 | 1 |
| Francois G. Ferre | 1 | 1 |
| Jorge G. Garces | 1 | 1 |
| Magda G. Marquet | 1 | 1 |
| Jorge Garces | 1 | 1 |
| Ann Kessler | 1 | 1 |
| Greg A Hamilton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.